nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.0343	0.0343	CcSEcCtD
Betaxolol—Kidney function abnormal—Adefovir Dipivoxil—hepatitis B	0.0327	0.0327	CcSEcCtD
Betaxolol—Rhinorrhoea—Telbivudine—hepatitis B	0.0164	0.0164	CcSEcCtD
Betaxolol—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0155	0.0155	CcSEcCtD
Betaxolol—Acidosis—Lamivudine—hepatitis B	0.0135	0.0135	CcSEcCtD
Betaxolol—Neck pain—Telbivudine—hepatitis B	0.0135	0.0135	CcSEcCtD
Betaxolol—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.012	0.012	CcSEcCtD
Betaxolol—Throat sore—Lamivudine—hepatitis B	0.0104	0.0104	CcSEcCtD
Betaxolol—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Betaxolol—Renal impairment—Telbivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0101	0.0101	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Entecavir—hepatitis B	0.00944	0.00944	CcSEcCtD
Betaxolol—Rhinorrhoea—Lamivudine—hepatitis B	0.00925	0.00925	CcSEcCtD
Betaxolol—Hyperglycaemia—Entecavir—hepatitis B	0.00916	0.00916	CcSEcCtD
Betaxolol—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00897	0.00897	CcSEcCtD
Betaxolol—Cramp muscle—Telbivudine—hepatitis B	0.00869	0.00869	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00869	0.00869	CcSEcCtD
Betaxolol—Nasopharyngitis—Telbivudine—hepatitis B	0.00863	0.00863	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00852	0.00852	CcSEcCtD
Betaxolol—Influenza—Telbivudine—hepatitis B	0.00834	0.00834	CcSEcCtD
Betaxolol—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00829	0.00829	CcSEcCtD
Betaxolol—Oropharyngeal pain—Lamivudine—hepatitis B	0.00824	0.00824	CcSEcCtD
Betaxolol—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00793	0.00793	CcSEcCtD
Betaxolol—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00787	0.00787	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00776	0.00776	CcSEcCtD
Betaxolol—Inflammation—Lamivudine—hepatitis B	0.00773	0.00773	CcSEcCtD
Betaxolol—Muscle twitching—Lamivudine—hepatitis B	0.00763	0.00763	CcSEcCtD
Betaxolol—Immune system disorder—Entecavir—hepatitis B	0.00734	0.00734	CcSEcCtD
Betaxolol—Neuropathy peripheral—Telbivudine—hepatitis B	0.00729	0.00729	CcSEcCtD
Betaxolol—Alopecia—Entecavir—hepatitis B	0.00719	0.00719	CcSEcCtD
Betaxolol—Mental disorder—Entecavir—hepatitis B	0.00712	0.00712	CcSEcCtD
Betaxolol—Malnutrition—Entecavir—hepatitis B	0.00708	0.00708	CcSEcCtD
Betaxolol—Neuropathy—Lamivudine—hepatitis B	0.00704	0.00704	CcSEcCtD
Betaxolol—Photophobia—Lamivudine—hepatitis B	0.00704	0.00704	CcSEcCtD
Betaxolol—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00691	0.00691	CcSEcCtD
Betaxolol—Mouth ulceration—Lamivudine—hepatitis B	0.00678	0.00678	CcSEcCtD
Betaxolol—Hypoaesthesia—Telbivudine—hepatitis B	0.00665	0.00665	CcSEcCtD
Betaxolol—Pharyngitis—Telbivudine—hepatitis B	0.00663	0.00663	CcSEcCtD
Betaxolol—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00638	0.00638	CcSEcCtD
Betaxolol—Lymphadenopathy—Lamivudine—hepatitis B	0.00638	0.00638	CcSEcCtD
Betaxolol—Sleep disorder—Lamivudine—hepatitis B	0.00629	0.00629	CcSEcCtD
Betaxolol—Deafness—Lamivudine—hepatitis B	0.00608	0.00608	CcSEcCtD
Betaxolol—Cough—Adefovir Dipivoxil—hepatitis B	0.00603	0.00603	CcSEcCtD
Betaxolol—Mediastinal disorder—Telbivudine—hepatitis B	0.00602	0.00602	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00598	0.00598	CcSEcCtD
Betaxolol—Injury—Lamivudine—hepatitis B	0.00592	0.00592	CcSEcCtD
Betaxolol—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00588	0.00588	CcSEcCtD
Betaxolol—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00588	0.00588	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00584	0.00584	CcSEcCtD
Betaxolol—Malnutrition—Telbivudine—hepatitis B	0.00581	0.00581	CcSEcCtD
Betaxolol—Infection—Entecavir—hepatitis B	0.00574	0.00574	CcSEcCtD
Betaxolol—Renal impairment—Lamivudine—hepatitis B	0.00572	0.00572	CcSEcCtD
Betaxolol—Thirst—Lamivudine—hepatitis B	0.00572	0.00572	CcSEcCtD
Betaxolol—Dysgeusia—Telbivudine—hepatitis B	0.00569	0.00569	CcSEcCtD
Betaxolol—Nervous system disorder—Entecavir—hepatitis B	0.00567	0.00567	CcSEcCtD
Betaxolol—Skin disorder—Entecavir—hepatitis B	0.00561	0.00561	CcSEcCtD
Betaxolol—Muscle spasms—Telbivudine—hepatitis B	0.00559	0.00559	CcSEcCtD
Betaxolol—Hypoglycaemia—Lamivudine—hepatitis B	0.00558	0.00558	CcSEcCtD
Betaxolol—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00553	0.00553	CcSEcCtD
Betaxolol—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00552	0.00552	CcSEcCtD
Betaxolol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00547	0.00547	CcSEcCtD
Betaxolol—Ill-defined disorder—Telbivudine—hepatitis B	0.00539	0.00539	CcSEcCtD
Betaxolol—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00537	0.00537	CcSEcCtD
Betaxolol—Affect lability—Lamivudine—hepatitis B	0.00536	0.00536	CcSEcCtD
Betaxolol—Malaise—Telbivudine—hepatitis B	0.00524	0.00524	CcSEcCtD
Betaxolol—Insomnia—Entecavir—hepatitis B	0.00522	0.00522	CcSEcCtD
Betaxolol—Mood swings—Lamivudine—hepatitis B	0.00515	0.00515	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00514	0.00514	CcSEcCtD
Betaxolol—Dyspepsia—Entecavir—hepatitis B	0.00508	0.00508	CcSEcCtD
Betaxolol—Cough—Telbivudine—hepatitis B	0.00507	0.00507	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Entecavir—hepatitis B	0.00499	0.00499	CcSEcCtD
Betaxolol—Fatigue—Entecavir—hepatitis B	0.00498	0.00498	CcSEcCtD
Betaxolol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00496	0.00496	CcSEcCtD
Betaxolol—Arthralgia—Telbivudine—hepatitis B	0.00495	0.00495	CcSEcCtD
Betaxolol—Chest pain—Telbivudine—hepatitis B	0.00495	0.00495	CcSEcCtD
Betaxolol—Myalgia—Telbivudine—hepatitis B	0.00495	0.00495	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00492	0.00492	CcSEcCtD
Betaxolol—Cramp muscle—Lamivudine—hepatitis B	0.0049	0.0049	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.0049	0.0049	CcSEcCtD
Betaxolol—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0049	0.0049	CcSEcCtD
Betaxolol—Discomfort—Telbivudine—hepatitis B	0.00489	0.00489	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00487	0.00487	CcSEcCtD
Betaxolol—Nasopharyngitis—Lamivudine—hepatitis B	0.00487	0.00487	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.0048	0.0048	CcSEcCtD
Betaxolol—Influenza—Lamivudine—hepatitis B	0.0047	0.0047	CcSEcCtD
Betaxolol—Dysphagia—Lamivudine—hepatitis B	0.0047	0.0047	CcSEcCtD
Betaxolol—Nervous system disorder—Telbivudine—hepatitis B	0.00465	0.00465	CcSEcCtD
Betaxolol—Thrombocytopenia—Telbivudine—hepatitis B	0.00465	0.00465	CcSEcCtD
Betaxolol—Skin disorder—Telbivudine—hepatitis B	0.00461	0.00461	CcSEcCtD
Betaxolol—Body temperature increased—Entecavir—hepatitis B	0.00457	0.00457	CcSEcCtD
Betaxolol—Bronchitis—Lamivudine—hepatitis B	0.00452	0.00452	CcSEcCtD
Betaxolol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00446	0.00446	CcSEcCtD
Betaxolol—Dysuria—Lamivudine—hepatitis B	0.0044	0.0044	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00432	0.00432	CcSEcCtD
Betaxolol—Insomnia—Telbivudine—hepatitis B	0.00429	0.00429	CcSEcCtD
Betaxolol—Paraesthesia—Telbivudine—hepatitis B	0.00426	0.00426	CcSEcCtD
Betaxolol—Hyperglycaemia—Lamivudine—hepatitis B	0.00424	0.00424	CcSEcCtD
Betaxolol—Depression—Lamivudine—hepatitis B	0.00418	0.00418	CcSEcCtD
Betaxolol—Dyspepsia—Telbivudine—hepatitis B	0.00418	0.00418	CcSEcCtD
Betaxolol—Asthenia—Entecavir—hepatitis B	0.00414	0.00414	CcSEcCtD
Betaxolol—Neuropathy peripheral—Lamivudine—hepatitis B	0.00411	0.00411	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0041	0.0041	CcSEcCtD
Betaxolol—Fatigue—Telbivudine—hepatitis B	0.00409	0.00409	CcSEcCtD
Betaxolol—Stomatitis—Lamivudine—hepatitis B	0.00409	0.00409	CcSEcCtD
Betaxolol—Pain—Telbivudine—hepatitis B	0.00406	0.00406	CcSEcCtD
Betaxolol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00404	0.00404	CcSEcCtD
Betaxolol—Sweating—Lamivudine—hepatitis B	0.00402	0.00402	CcSEcCtD
Betaxolol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00399	0.00399	CcSEcCtD
Betaxolol—Epistaxis—Lamivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Betaxolol—Diarrhoea—Entecavir—hepatitis B	0.00395	0.00395	CcSEcCtD
Betaxolol—Sinusitis—Lamivudine—hepatitis B	0.00393	0.00393	CcSEcCtD
Betaxolol—Agranulocytosis—Lamivudine—hepatitis B	0.00391	0.00391	CcSEcCtD
Betaxolol—Feeling abnormal—Telbivudine—hepatitis B	0.00391	0.00391	CcSEcCtD
Betaxolol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00386	0.00386	CcSEcCtD
Betaxolol—Dizziness—Entecavir—hepatitis B	0.00382	0.00382	CcSEcCtD
Betaxolol—Rhinitis—Lamivudine—hepatitis B	0.00377	0.00377	CcSEcCtD
Betaxolol—Body temperature increased—Telbivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Betaxolol—Hypoaesthesia—Lamivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Betaxolol—Pharyngitis—Lamivudine—hepatitis B	0.00374	0.00374	CcSEcCtD
Betaxolol—Vomiting—Entecavir—hepatitis B	0.00367	0.00367	CcSEcCtD
Betaxolol—Rash—Entecavir—hepatitis B	0.00364	0.00364	CcSEcCtD
Betaxolol—Dermatitis—Entecavir—hepatitis B	0.00364	0.00364	CcSEcCtD
Betaxolol—Headache—Entecavir—hepatitis B	0.00362	0.00362	CcSEcCtD
Betaxolol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00358	0.00358	CcSEcCtD
Betaxolol—Rash—Adefovir Dipivoxil—hepatitis B	0.00355	0.00355	CcSEcCtD
Betaxolol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00355	0.00355	CcSEcCtD
Betaxolol—Headache—Adefovir Dipivoxil—hepatitis B	0.00353	0.00353	CcSEcCtD
Betaxolol—Nausea—Entecavir—hepatitis B	0.00343	0.00343	CcSEcCtD
Betaxolol—Asthenia—Telbivudine—hepatitis B	0.0034	0.0034	CcSEcCtD
Betaxolol—Immune system disorder—Lamivudine—hepatitis B	0.0034	0.0034	CcSEcCtD
Betaxolol—Mediastinal disorder—Lamivudine—hepatitis B	0.00339	0.00339	CcSEcCtD
Betaxolol—Chills—Lamivudine—hepatitis B	0.00338	0.00338	CcSEcCtD
Betaxolol—Pruritus—Telbivudine—hepatitis B	0.00336	0.00336	CcSEcCtD
Betaxolol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00335	0.00335	CcSEcCtD
Betaxolol—Alopecia—Lamivudine—hepatitis B	0.00333	0.00333	CcSEcCtD
Betaxolol—Malnutrition—Lamivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Betaxolol—Erythema—Lamivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Betaxolol—Diarrhoea—Telbivudine—hepatitis B	0.00325	0.00325	CcSEcCtD
Betaxolol—Tension—Lamivudine—hepatitis B	0.00322	0.00322	CcSEcCtD
Betaxolol—Dysgeusia—Lamivudine—hepatitis B	0.00321	0.00321	CcSEcCtD
Betaxolol—Nervousness—Lamivudine—hepatitis B	0.00318	0.00318	CcSEcCtD
Betaxolol—Muscle spasms—Lamivudine—hepatitis B	0.00315	0.00315	CcSEcCtD
Betaxolol—Dizziness—Telbivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Betaxolol—Tremor—Lamivudine—hepatitis B	0.00307	0.00307	CcSEcCtD
Betaxolol—Ill-defined disorder—Lamivudine—hepatitis B	0.00304	0.00304	CcSEcCtD
Betaxolol—Anaemia—Lamivudine—hepatitis B	0.00303	0.00303	CcSEcCtD
Betaxolol—Vomiting—Telbivudine—hepatitis B	0.00302	0.00302	CcSEcCtD
Betaxolol—Rash—Telbivudine—hepatitis B	0.00299	0.00299	CcSEcCtD
Betaxolol—Dermatitis—Telbivudine—hepatitis B	0.00299	0.00299	CcSEcCtD
Betaxolol—Headache—Telbivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Betaxolol—Malaise—Lamivudine—hepatitis B	0.00296	0.00296	CcSEcCtD
Betaxolol—Vertigo—Lamivudine—hepatitis B	0.00294	0.00294	CcSEcCtD
Betaxolol—Syncope—Lamivudine—hepatitis B	0.00294	0.00294	CcSEcCtD
Betaxolol—Loss of consciousness—Lamivudine—hepatitis B	0.00288	0.00288	CcSEcCtD
Betaxolol—Cough—Lamivudine—hepatitis B	0.00286	0.00286	CcSEcCtD
Betaxolol—Nausea—Telbivudine—hepatitis B	0.00282	0.00282	CcSEcCtD
Betaxolol—Chest pain—Lamivudine—hepatitis B	0.00279	0.00279	CcSEcCtD
Betaxolol—Myalgia—Lamivudine—hepatitis B	0.00279	0.00279	CcSEcCtD
Betaxolol—Arthralgia—Lamivudine—hepatitis B	0.00279	0.00279	CcSEcCtD
Betaxolol—Anxiety—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00277	0.00277	CcSEcCtD
Betaxolol—Discomfort—Lamivudine—hepatitis B	0.00276	0.00276	CcSEcCtD
Betaxolol—Dry mouth—Lamivudine—hepatitis B	0.00273	0.00273	CcSEcCtD
Betaxolol—Confusional state—Lamivudine—hepatitis B	0.0027	0.0027	CcSEcCtD
Betaxolol—Oedema—Lamivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Betaxolol—Infection—Lamivudine—hepatitis B	0.00266	0.00266	CcSEcCtD
Betaxolol—Shock—Lamivudine—hepatitis B	0.00263	0.00263	CcSEcCtD
Betaxolol—Nervous system disorder—Lamivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Betaxolol—Thrombocytopenia—Lamivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Betaxolol—Skin disorder—Lamivudine—hepatitis B	0.0026	0.0026	CcSEcCtD
Betaxolol—Hyperhidrosis—Lamivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Betaxolol—Anorexia—Lamivudine—hepatitis B	0.00255	0.00255	CcSEcCtD
Betaxolol—Hypotension—Lamivudine—hepatitis B	0.0025	0.0025	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00244	0.00244	CcSEcCtD
Betaxolol—Insomnia—Lamivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Betaxolol—Paraesthesia—Lamivudine—hepatitis B	0.0024	0.0024	CcSEcCtD
Betaxolol—Dyspnoea—Lamivudine—hepatitis B	0.00238	0.00238	CcSEcCtD
Betaxolol—Dyspepsia—Lamivudine—hepatitis B	0.00235	0.00235	CcSEcCtD
Betaxolol—Decreased appetite—Lamivudine—hepatitis B	0.00232	0.00232	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00231	0.00231	CcSEcCtD
Betaxolol—Fatigue—Lamivudine—hepatitis B	0.00231	0.00231	CcSEcCtD
Betaxolol—Pain—Lamivudine—hepatitis B	0.00229	0.00229	CcSEcCtD
Betaxolol—Constipation—Lamivudine—hepatitis B	0.00229	0.00229	CcSEcCtD
Betaxolol—Feeling abnormal—Lamivudine—hepatitis B	0.0022	0.0022	CcSEcCtD
Betaxolol—Urticaria—Lamivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Betaxolol—Body temperature increased—Lamivudine—hepatitis B	0.00211	0.00211	CcSEcCtD
Betaxolol—Hypersensitivity—Lamivudine—hepatitis B	0.00197	0.00197	CcSEcCtD
Betaxolol—Asthenia—Lamivudine—hepatitis B	0.00192	0.00192	CcSEcCtD
Betaxolol—Pruritus—Lamivudine—hepatitis B	0.00189	0.00189	CcSEcCtD
Betaxolol—Diarrhoea—Lamivudine—hepatitis B	0.00183	0.00183	CcSEcCtD
Betaxolol—Dizziness—Lamivudine—hepatitis B	0.00177	0.00177	CcSEcCtD
Betaxolol—Vomiting—Lamivudine—hepatitis B	0.0017	0.0017	CcSEcCtD
Betaxolol—Rash—Lamivudine—hepatitis B	0.00169	0.00169	CcSEcCtD
Betaxolol—Dermatitis—Lamivudine—hepatitis B	0.00168	0.00168	CcSEcCtD
Betaxolol—Headache—Lamivudine—hepatitis B	0.00168	0.00168	CcSEcCtD
Betaxolol—Nausea—Lamivudine—hepatitis B	0.00159	0.00159	CcSEcCtD
